Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
38%
OVERLAP
BY WEIGHT
6
# OF OVERLAPPING
HOLDINGS
PPH
26
HOLDINGS
26%
ALSO IN THNR
THNR
20
HOLDINGS
30%
ALSO IN PPH
SECTOR DRIFT (PPH minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 16.7% | 11.4% | 11.4% |
 |
NOVO-NORDISK A/S-SPONS ADR | 6.1% | 9.1% | 6.1% |
|
MERCK & CO. INC. | 6.4% | 5.5% | 5.5% |
|
ABBVIE INC | 5.0% | 5.7% | 5.0% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.0% | 5.6% | 5.0% |
PPH Overweight Relative to THNR
|
JOHNSON & JOHNSON | 11.6% |
 |
NOVARTIS AG-ADR | 7.9% |
|
ELI LILLY & CO | 5.3% |
 |
SANOFI-AVENTIS-ADR | 4.7% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 4.4% |
|
MCKESSON CORP | 4.4% |
|
BRISTOL-MYERS SQUIBB CO | 4.4% |
|
ZOETIS INC | 4.3% |
|
CENCORA INC | 3.7% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 2.9% |
PPH Underweight Relative to THNR
|
REGENERON PHARMACEUTICALS | -7.8% |
|
AMGEN INC | -6.8% |
|
CHUGAI PHARMACEUTICAL CO LTD | -5.6% |
|
GILEAD SCIENCES INC | -5.3% |
 |
INNOVENT BIOLOGICS, INC. | -5.2% |
|
ROCHE HOLDING LTD | -5.0% |
 |
CHINA PHARMACEUTICAL GROUP | -4.9% |
|
SHIONOGI & CO LTD | -4.3% |
|
HIMS & HERS HEALTH, INC. CLASS A | -3.3% |
|
NOVO-NORDISK A/S-SPONS ADR | -3.0% |